Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 60.00% vs 400.00% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -100.00% vs 0.00% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 3,401.64% vs 154.17% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 5,720.00% vs -78.26% in Mar 2024
Compare Balance Sheet Results of Bacil Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
13.97
9.22
4.75
51.52%
Share Warrants & Outstandings
Total Reserve
11.46
5.43
6.03
111.05%
Shareholder's Funds
25.43
14.65
10.78
73.58%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
3.79
-3.79
-100.00%
Secured Loans
0.00
3.08
-3.08
-100.00%
Unsecured Loans
0.00
0.71
-0.71
-100.00%
Deferred Tax Assets / Liabilities
-0.05
0.91
-0.96
-105.49%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.80
-0.80
-100.00%
Total Non-Current Liabilities
-0.05
5.50
-5.55
-100.91%
Current Liabilities
Trade Payables
0.00
33.61
-33.61
-100.00%
Other Current Liabilities
0.00
4.08
-4.08
-100.00%
Short Term Borrowings
0.16
36.26
-36.10
-99.56%
Short Term Provisions
0.00
0.44
-0.44
-100.00%
Total Current Liabilities
0.17
74.39
-74.22
-99.77%
Total Liabilities
25.55
94.54
-68.99
-72.97%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.06
50.69
-50.63
-99.88%
Less: Accumulated Depreciation
0.06
25.23
-25.17
-99.76%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.00
25.46
-25.46
-100.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
21.36
0.21
21.15
10,071.43%
Long Term Loans & Advances
1.28
0.67
0.61
91.04%
Other Non Current Assets
0.00
0.81
-0.81
-100.00%
Total Non-Current Assets
22.64
27.15
-4.51
-16.61%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.00
49.97
-49.97
-100.00%
Sundry Debtors
0.00
13.25
-13.25
-100.00%
Cash and Bank
2.86
0.67
2.19
326.87%
Other Current Assets
0.00
1.72
-1.72
-100.00%
Short Term Loans and Advances
0.05
1.79
-1.74
-97.21%
Total Current Assets
2.91
67.39
-64.48
-95.68%
Net Current Assets (Including Current Investments)
2.74
-7.00
9.74
139.14%
Total Current Assets Excluding Current Investments
2.91
67.39
-64.48
-95.68%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
25.55
94.54
-68.99
-72.97%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.16
40.05
-39.89
-99.60%
Book Value per share (adjusted)
18.20
15.89
2.31
14.54%
Annual - Borrowings
Borrowings 0.16 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 60.00% vs 400.00% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 0.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -100.00% vs 0.00% in Mar 2024
Annual - Investments
Investments 21.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 3,401.64% vs 154.17% in Mar 2024
Annual - Current Assets
Current Assets 2.91 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 5,720.00% vs -78.26% in Mar 2024
